Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes
about
Maternal low thyroxin levels are associated with adverse pregnancy outcomes in a Chinese population.Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement.Glucose and angiotensin II-derived endothelial extracellular vesicles regulate endothelial dysfunction via ERK1/2 activation.Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats.In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats.Purinergic Signalling: Therapeutic Developments.Impaired Aortic Contractility to Uridine Adenosine Tetraphosphate in Angiotensin II-Induced Hypertensive Mice: Receptor Desensitization?Alteration of Vascular Responsiveness to Uridine Adenosine Tetraphosphate in Aortas Isolated from Male Diabetic Otsuka Long-Evans Tokushima Fatty Rats: The Involvement of Prostanoids.UDP-induced relaxation is enhanced in aorta from female obese Otsuka Long-Evans Tokushima Fatty rats.Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace α1 -Adrenergic Tension in the Human Prostate.Metformin prevents vascular prostanoid release alterations induced by a high-fat diet in rats.Relationship between PDK1 and contraction in carotid arteries in Goto-Kakizaki rat, a spontaneous type 2 diabetic animal model.Multiple activation mechanisms of serotonin-mediated contraction in the carotid arteries obtained from spontaneously hypertensive rats.Insulin augments serotonin-induced contraction via activation of the IR/PI3K/PDK1 pathway in the rat carotid artery.
P2860
Q33719061-EB7AAFF1-A1C9-4D46-8C1F-5A8C8DDA8815Q38679517-4BC7BAB8-3B97-4173-BB0D-62EAE5B678DAQ39099983-15667DDC-7F69-4B58-8B5F-0B5E3F2320A6Q39378416-FFE4819D-BD8B-478E-B6D4-D972BC7E7BF4Q42073707-FA569952-67B2-4595-A3E4-0E6610582083Q42367885-058F4FA0-019C-481B-A3FE-6860D474F6AAQ45049857-60292EDA-FEFF-4328-86BA-61D62E59B310Q47157747-97027EF5-D77D-4F10-93D9-002CE3B749D4Q47571343-ABC4FCFC-BBDF-4ABF-B4E9-536BFAA90F6DQ47997829-73D0D4C8-EF17-475E-88BB-2CD9A62F3BACQ48267057-D615FA54-1E22-4DE4-B603-61E5C17068B3Q50935134-03770603-DB89-4EEC-8EEE-E5E6DF6C7EACQ53102843-9A5AF7B2-08C9-483B-9E1A-73B3E8E87934Q53274334-3139FE69-BF5B-4CCF-B78C-5310AA594BDF
P2860
Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Constrictor prostanoids and ur ...... s in hypertension and diabetes
@ast
Constrictor prostanoids and ur ...... s in hypertension and diabetes
@en
Constrictor prostanoids and ur ...... s in hypertension and diabetes
@nl
type
label
Constrictor prostanoids and ur ...... s in hypertension and diabetes
@ast
Constrictor prostanoids and ur ...... s in hypertension and diabetes
@en
Constrictor prostanoids and ur ...... s in hypertension and diabetes
@nl
prefLabel
Constrictor prostanoids and ur ...... s in hypertension and diabetes
@ast
Constrictor prostanoids and ur ...... s in hypertension and diabetes
@en
Constrictor prostanoids and ur ...... s in hypertension and diabetes
@nl
P2093
P2860
P356
P1476
Constrictor prostanoids and ur ...... s in hypertension and diabetes
@en
P2093
Kumiko Taguchi
Styliani Goulopoulou
Takayuki Matsumoto
Tsuneo Kobayashi
P2860
P304
P356
10.1111/BPH.13205
P407
P577
2015-07-08T00:00:00Z